AXT, Inc. Q4 FY2025 Earnings Call
· Earnings call transcript and AI-powered summary
Financial Performance Highlights
- Revenue: $23.0 million in Q4 2025, down from $28.0 million in Q3 2025 and $25.1 million in Q4 2024. Product breakdown: Indium Phosphide $8.0M (data center focus), Gallium Arsenide $7.0M, Germanium $0.231M, Raw materials JV $7.6M. Geographic: Asia Pacific 81.5%, Europe 17.5%, North America 1%.
- Gross Margin: Non-GAAP 21.5% in Q4 2025 (vs. 22.6% in Q3 2025, improved from 18.0% in Q4 2024). GAAP 20.9% (vs. 22.3% Q3 2025, 17.6% Q4 2024).
- Operating Expenses: Non-GAAP $7.8M in Q4 2025 (vs. $6.5M Q3 2025 due to prior favorable adjustments; down from $9.8M Q4 2024). GAAP $8.8M (vs. $7.3M Q3, $10.6M Q4 2024).
- Operating Loss: Non-GAAP $2.6M in Q4 2025 (vs. $0.384M Q3 2025; improved from $5.4M Q4 2024). GAAP loss $3.8M (vs. $1.1M Q3, $6.2M Q4 2024).
- Net Loss: Non-GAAP $2.6M or $0.06/share (vs. $1.2M or $0.02/share Q3 2025; improved from $4.2M or $0.10/share Q4 2024). GAAP $3.6M or $0.08/share (vs. $1.9M or $0.04/share Q3 2025; improved from $5.1M or $0.12/share Q4 2024).
- Balance Sheet: Cash, equivalents & investments rose to $128.4M (up $97.2M from Q3, primarily from $93.9M public stock offering). Inventory up $4M to $81.7M. Depreciation $2.3M; stock comp $1.3M. Shares outstanding: 44.7M basic.